Chopas James George

Principal Finance Accounting at MPM ACQUISITION CORP · on record since Dec 18, 2020
VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. · on record since Sep 1, 2021

Insider trading activity of Chopas James George

Transactions on record: 60; since Jan 21, 2021

Open-market buys: 0

Open-market sells: 17; $382.7K

Companies traded: 2; last filing May 14, 2026

Figures computed from official regulatory filings — methodology.

Companies where Chopas James George has traded

Apellis Pharmaceuticals, Inc.57 tx · $2.3M · May 14, 2026
MPM ACQUISITION CORP3 tx · $7.7K · Mar 9, 2021

Track record of Chopas James George

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Chopas James George

Co-insiders of Chopas James George

Adler Lundgren Tamara L.MPM ACQUISITION CORP
AJU IB Investment Co., Ltd.Apellis Pharmaceuticals, Inc.
AUERBACH ALAN HMPM ACQUISITION CORP
Axon StevenApellis Pharmaceuticals, Inc.
Baumal CarolineApellis Pharmaceuticals, Inc.
BB BIOTECH AGMPM ACQUISITION CORP
BIOGEN IDEC INCApellis Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-11,250	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-8,394	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-21,750	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-15,114	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	8,075	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-5,625	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-4,156	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-16,150	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-9,444	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	8,394	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-20,853	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-6,250	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-12,086	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-16,150	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-8,075	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	5,625	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	16,150	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-2,406	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-65,955	—	—	SEC
Apellis Pharmaceuticals, Inc.	Jan 30, 2026	Award	16,150	0.00 USD	$0	SEC
Apellis Pharmaceuticals, Inc.	Jan 23, 2026	Sell	-2,064	21.77 USD	$44.9K	SEC
Apellis Pharmaceuticals, Inc.	Jan 21, 2026	Sell	-726	19.79 USD	$14.4K	SEC
Apellis Pharmaceuticals, Inc.	Jan 15, 2026	Sell	-873	22.19 USD	$19.4K	SEC
Apellis Pharmaceuticals, Inc.	Sep 17, 2025	Sell	-189	24.19 USD	$4.6K	SEC
Apellis Pharmaceuticals, Inc.	Sep 3, 2025	Sell	-548	28.08 USD	$15.4K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-11,250	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-8,394	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-21,750	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-15,114	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	8,075	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-5,625	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-4,156	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-16,150	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-9,444	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	8,394	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-20,853	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-6,250	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	OtherD	-12,086	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-16,150	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-8,075	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	5,625	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Award	16,150	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-2,406	—	—	SEC
Apellis Pharmaceuticals, Inc.	May 14, 2026	Other	-65,955	—	—	SEC
Apellis Pharmaceuticals, Inc.	Jan 30, 2026	Award	16,150	0.00 USD	$0	SEC
Apellis Pharmaceuticals, Inc.	Jan 23, 2026	Sell	-2,064	21.77 USD	$44.9K	SEC
Apellis Pharmaceuticals, Inc.	Jan 21, 2026	Sell	-726	19.79 USD	$14.4K	SEC
Apellis Pharmaceuticals, Inc.	Jan 15, 2026	Sell	-873	22.19 USD	$19.4K	SEC
Apellis Pharmaceuticals, Inc.	Sep 17, 2025	Sell	-189	24.19 USD	$4.6K	SEC
Apellis Pharmaceuticals, Inc.	Sep 3, 2025	Sell	-548	28.08 USD	$15.4K	SEC